Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children

Journal of Allergy and Clinical Immunology

Volumn 108, Issue 1 SUPPL., 2001, Pages

  Boner, Attilio L ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Adrenal corticotropic hormone; Beclamethasone dipropionate; Corticosteroid; Cortisol; Flunisolide; Fluticasone propionate; Hypothalamus; Intranasal corticosteroid; Mometasone furoate; Triamcinolone acetonide

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; HYDROCORTISONE; MOMETASONE FUROATE; TETRACOSACTIDE;

ADRENAL FUNCTION; ALLERGIC RHINITIS; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG SENSITIVITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; URINE LEVEL; URINE VOLUME;

EID: 0034912051     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.115564     Document Type: Article

References (59)

1. Glucocorticosteroids and rhinitis
2. Efficacy of safety of concurrent use of intranasal flunisolide and oral beclomethasone aerosols in treatment of asthmatics with rhinitis
3. Inhaled glucocorticoid therapy in children: How much is safe?
4. The adrenal cortex
5. Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate
6. A rational approach for assessing the hypothalamo-pituitary-adrenal axis
7. The effect of an inhaled steroid on the hypothalamic-pituitary-adrenal axis: Which tests should be used?
8. Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids
9. Hypothalamic-pituitary-adrenal axis
10. Adrenocortical function in children on high-dose steroid aerosol therapy: Results of serum cortisol, ACTH stimulation test and 24 hour urinary-free cortical excretion
11. Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids
12. Measuring the systemic effects of inhaled beclomethasone: Timed morning urine collections compared with 24 hour specimens
13. Hypocortisolemia in children undergoing evaluation for growth hormone deficiency
14. A comparative study of urinary 17-hydroxycorticosteroids, urinary free cortisol, and the integrated concentration of plasma cortisol
15. Integrated plasma cortisol concentration in children with asthma receiving long-term inhaled corticosteroids
16. Normal cortisol response to corticotropin in patients with secondary, adrenal failure
17. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids
18. Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity
19. Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of adrenocortical activity in healthy volunteers
20. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone
21. Further studies of the effects of inhaled glucocorticoids on pituitary-adrenal function in healthy adults
22. The short metyrapone test: Comparison of the plasma ACTH response to metyrapone and insulin-induced hyperglycaemia
23. Fluticasone propionate: Topical or systemic effects?
24. Treatment of seasonal allergic rhinitis with once-daily intranasal fluticasone propionate therapy in children
25. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis
26. Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice-daily
27. Fluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitis
28. Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function
29. A clinical comparison of intranasal budesonide with beclomethasone dipropionate for perennial non-allergic rhinitis: A 12 month study
30. Nasal powder administration of budesonide for seasonal rhinitis in children and adolescents
31. Long-term safety and efficacy of budesonide nasal aerosol in perennial rhinitis: A 12-month multicentre study
32. Systemic effects of two nasally administered glucocorticosteroids
33. Activation of beclomethasone dipropionate by hydrolysis to beclomethasone-17-monopropionate
34. Safety of intranasal beclomethasone dipropionate: A review
35. A comparison of intranasal beclomethasone dipropionate with other agents in the treatment of rhinitis: A review of published clinical experience
36. An evaluation of the effects of beclomethasone dipropionate aqueous nasal spray (Vancenase AQ (VNS)) on long-term growth in children
37. Lysine-vasopressin in the evaluation of the hypothalamic-pituitary-adrenal axis in children with allergic rhinitis treated with intranasal beclomethasone dipropionate or oral prednisone
38. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate
39. A comparison of intranasal and oral flunisolide in the therapy of allergic rhinitis: Evidence for a topical effect
40. A comparison of effects of triamcinolone acetonide aqueous nasal spray, oral prednisone, and placebo on adrenocortical function in male patients with allergic rhinitis
41. Long-term safety of triamcinolone acetonide nasal aerosol for the treatment of perennial allergic rhinitis
42. A comparative study of the effects of intranasal triamcinolone acetonide aerosol (ITAA) and prednisone on adrenocortical function
43. Multicenter evaluation of triamcinolone acetonide nasal aerosol in the treatment of adult patients with seasonal allergic rhinitis
44. Twenty-four-hour adrenocortical profiles in asthmatics receiving inhaled and intranasal corticosteroids
45. The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis
46. Once-daily mometasone furoate nasal spray: Efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis
47. Lack of systemic activity with intranasal mometasone furoate
48. Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children
49. A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis
50. Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis
51. Absence of growth retardation in children with perennial allergic rhinitis following 1 year of treatment with mometasone furoate aqueous nasal spray
52. Recovery of hypothalamo-pituitary-adrenal function in asthmatics whose oral steroids have been stopped or reduced
53. Efficacy and safety of inhaled corticosteroids: New developments
54. Pharmacokinetics of budesonide in children with asthma
55. Efficacy and safety of inhaled corticosteroids in children
56. Treatment options for the child with allergic rhinitis
57. Iatrogenic Cushing's syndrome due to dexamethasone nasal drops
58. Six-week trial of nebulized flunisolide nasal spray: Efficacy in young children with moderately severe asthma